Prestige Wealth Management Group LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1772715 FLEMINGTON, NJ

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,107

+$3,399 QoQ

Shares Held

124

+15.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#445

of 499 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Prestige Wealth Management Group LLC holds $465,680 across 25 Biotechnology names. ARWR ranks #6 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	556	$276,181
2	ALNY	Alnylam Pharmaceuticals, Inc.	201	$60,507
3	REGN	Regeneron Pharmaceuticals, Inc.	63	$39,282
4	CMPX	Compass Therapeutics, Inc.	7,750	$16,972
5	INCY	Incyte Corp	132	$14,963
6	ARWR	Arrowhead Pharmaceuticals, Inc. This page	124	$10,107
7	MRNA	Moderna, Inc.	137	$9,594
8	STOK	Stoke Therapeutics, Inc.	200	$6,544

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,107	124	+15.9%	Shares	Other	2026-08-14
2026-03-31	$6,708	107	+7.0%	Shares	Other	2026-05-13
2025-12-31	$6,639	100	0.0%	Shares	Other	2026-02-11
2025-09-30	$3,449	100	-39.4%	Shares	Other	2026-02-20
2025-06-30	$2,607	165	+153.8%	Shares	Other	2026-02-20
2025-03-31	$828	65	0.0%	Shares	Sole	2026-02-20
2024-12-31	$1,222	65	0.0%	Shares	Sole	2026-02-20
2024-09-30	$1,259	65	+622.2%	Shares	Sole	2026-02-20
2022-03-31	$413	9	0.0%	Shares	Other	2022-05-05
2021-12-31	$596	9	+50.0%	Shares	Other	2022-02-15
2021-09-30	$374	6	—	Shares	Other	2021-11-12
No filing history on record for this holder in this stock.